GNF-Pf-3149

ID: ALA582507

Chembl Id: CHEMBL582507

Cas Number: 484039-79-4

PubChem CID: 651603

Max Phase: Preclinical

Molecular Formula: C17H12N6O

Molecular Weight: 316.32

Molecule Type: Small molecule

Names and Identifiers

Synonyms: GNF-Pf-3149 | N-Quinolin-3-yl-3-tetrazol-1-yl-benzamide|GNF-Pf-3149|MLS000032104|MMV084864|SMR000002253|regid849132|N-quinolin-3-yl-3-(tetrazol-1-yl)benzamide|Oprea1_014873|CHEMBL582507|cid_651603|BDBM74559|DTXSID901346341|HMS2409F11|AKOS033879247|484039-79-4|PD061226|N-(3-quinolinyl)-3-(1-tetrazolyl)benzamide|N-(3-quinolyl)-3-(tetrazol-1-yl)benzamide|SR-01000610696|SR-01000610696-2|N-quinolin-3-yl-3-(1,2,3,4-tetrazol-1-yl)benzamide

Canonical SMILES:  O=C(Nc1cnc2ccccc2c1)c1cccc(-n2cnnn2)c1

Standard InChI:  InChI=1S/C17H12N6O/c24-17(13-5-3-6-15(9-13)23-11-19-21-22-23)20-14-8-12-4-1-2-7-16(12)18-10-14/h1-11H,(H,20,24)

Standard InChI Key:  BKHIUIHGKIWMST-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA582507

   N-Quinolin-3-yl-3-tetrazol-1-yl-benzamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 316.32

Molecular Weight (Monoisotopic): 316.1073

AlogP: 2.46

#Rotatable Bonds: 3

Polar Surface Area: 85.59

Molecular Species: NEUTRAL

HBA: 6

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 3.62

CX LogP: 2.26

CX LogD: 2.26

Aromatic Rings: 4

Heavy Atoms: 24

QED Weighted: 0.63

Np Likeness Score: -2.81

References

1. Plouffe D, Brinker A, McNamara C, Henson K, Kato N, Kuhen K, Nagle A, Adrián F, Matzen JT, Anderson P, Nam TG, Gray NS, Chatterjee A, Janes J, Yan SF, Trager R, Caldwell JS, Schultz PG, Zhou Y, Winzeler EA..  (2008)  In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.,  105  (26): [PMID:18579783] [10.1073/pnas.0802982105]

2. PubChem BioAssay data set, 

3. Meister S, Plouffe DM, Kuhen KL, Bonamy GM, Wu T, Barnes SW, Bopp SE, Borboa R, Bright AT, Che J, Cohen S, Dharia NV, Gagaring K, Gettayacamin M, Gordon P, Groessl T, Kato N, Lee MC, McNamara CW, Fidock DA, Nagle A, Nam TG, Richmond W, Roland J, Rottmann M, Zhou B, Froissard P, Glynne RJ, Mazier D, Sattabongkot J, Schultz PG, Tuntland T, Walker JR, Zhou Y, Chatterjee A, Diagana TT, Winzeler EA..  (2011)  Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.,  334  (6061): [PMID:22096101] [10.1126/science.1211936]

4. MMV Pathogen Box,  [10.6019/CHEMBL3637841]

5. Nathan group, Weill Cornell Medical College; Barry Lab, NIAID NIH; Winzeler lab, UCSD; Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Univ. of Antwerp; London School of Hygiene and Tropical Medicine; Parasite Chemotherapy Unit at Swiss Tropical and Public Health Institute; Huston group at the University of Vermont; Castellanos group at UTMB, Galveston, Texas; Sakanari Lab, Univ. of Calif. San Francisco; Townson (Simon) Lab, Imperial College London; Fidelis Cho-Ngwa Lab, University of Buea, Buea, Cameroon; Laboratory of Molecular Parasitology at the New York Blood Center; Bickle Lab, London School of Hygiene and Tropical Medicine; Keiser Lab, Swiss Tropical and Public Health Institute; Caffrey group at the Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego; University of Cape Town; Shanmugam group at CSIR-National Chemical Laboratory, Pune (India); Novartis Institute for Tropical Disease-Singapore; Abbvie. MMV Pathogen Box Bioactivity Data,  [10.6019/CHEMBL3832761]

6. Anna Ehmann. The Australian National University Dept Of Immunology Pathogen Box Compounds Screened,  [10.6019/CHEMBL3987221]

7. Sarink, M; Mykytyn, A; Tielens, A; van Hellemond, J. Naegleria gruberi Pathogen Box compounds screening,  [10.6019/CHEMBL4513101]

8. Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper. CO-ADD screening of MMV (CH) - MMV compounds,  [10.6019/CHEMBL4513149]

Source

Source(4):

• Novartis Malaria Screening
• PubChem BioAssays
• MMV Pathogen Box
• CO-ADD antimicrobial screening data